Author: Mallach, Gary; Kasloff, Samantha B.; Kovesi, Tom; Kumar, Anand; Kulka, Ryan; Krishnan, Jay; Robert, Benoit; McGuinty, Michaeline; den Otter-Moore, Sophia; Yazji, Bashour; Cutts, Todd
Title: Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic Cord-id: lro9g4oc Document date: 2021_9_30
ID: lro9g4oc
Snippet: BACKGROUND: Few studies have quantified aerosol concentrations of SARS-CoV-2 in hospitals and long-term care homes, and fewer still have examined samples for viability. This information is needed to clarify transmission risks beyond close contact. METHODS: We deployed particulate air samplers in rooms with COVID-19 positive patients in hospital ward and ICU rooms, rooms in long-term care homes experiencing outbreaks, and a correctional facility experiencing an outbreak. Samplers were placed betw
Document: BACKGROUND: Few studies have quantified aerosol concentrations of SARS-CoV-2 in hospitals and long-term care homes, and fewer still have examined samples for viability. This information is needed to clarify transmission risks beyond close contact. METHODS: We deployed particulate air samplers in rooms with COVID-19 positive patients in hospital ward and ICU rooms, rooms in long-term care homes experiencing outbreaks, and a correctional facility experiencing an outbreak. Samplers were placed between 2 and 3 meters from the patient. Aerosol (small liquid particles suspended in air) samples were collected onto gelatin filters by Ultrasonic Personal Air Samplers (UPAS) fitted with <2.5μm (micrometer) and <10 μm size-selective inlets operated for 16 hours (total 1.92m(3)), and with a Coriolis Biosampler over 10 minutes (total 1.5m(3)). Samples were assayed for viable SARS-CoV-2 virus and for the viral genome by multiplex PCR using the E and N protein target sequences. We validated the sampling methods by inoculating gelatin filters with viable vesicular stomatitis virus (VSV), and with three concentrations of viable SARS-CoV-2, operating personal samplers for 16hrs, and quantifying viable virus recovery by TCID(50) assay. RESULTS: In total, 138 samples were collected from 99 rooms. RNA samples were positive in 9.1% (6/66) of samples obtained with the UPAS 2.5μm samplers, 13.5% (7/52) with the UPAS 10μm samplers, and 10.0% (2/20) samples obtained with the Coriolis samplers. Culturable virus was not recovered in any samples. Viral RNA was detected in 15.1% of the rooms sampled. There was no significant difference in viral RNA recovery between the different room locations or samplers. Method development experiments indicated minimal loss of SARS-CoV-2 viability via the personal air sampler operation.
Search related documents:
Co phrase search for related documents- acid detection and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acid detection and logistic regression model: 1, 2, 3, 4
- acid detection and long duration: 1
- acid detection and long period: 1, 2, 3
- active disease and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active disease and logistic regression model: 1, 2
- active disease and long period: 1, 2, 3
- activity limitation and additional information: 1
- activity limitation and logistic regression: 1, 2, 3, 4
- activity limitation and long period: 1
- additional information and living area: 1
- additional information and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- additional information and logistic regression model: 1, 2, 3
- additional information and long duration: 1
- adjacent room and long period: 1
- living area and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- living area and logistic regression model: 1, 2, 3, 4
- logistic regression and long duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- logistic regression and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date